Journal
ACTA OTORHINOLARYNGOLOGICA ITALICA
Volume 39, Issue 4, Pages 235-243Publisher
PACINI EDITORE
DOI: 10.14639/0392-100X-2409
Keywords
Open partial horizontal laryngectomy; Supracricoid partial laryngectomy; Supratracheal partial laryngectomy; Recurrence; Laryngeal cancer; Multivariate analysis
Categories
Funding
- Italian Society of Otorhinolaryngology, Head and Neck Surgery
- FPRC 5xmille Ministero Salute 2016 (Progetto Approccio di ricerca diagnostico e terapeutico al paziente con Tumori del Colon Retto del distretto cervico-facciale ARIDTE-Biohenec)
Ask authors/readers for more resources
In choosing the best surgical treatment (total or partial laryngectomy) for patients affected by laryngeal squamous cell carcinoma (SCC), it is still necessary to identify a link between prognostic factors and oncological outcomes. A retrospective analysis of clinical outcomes of 819 patients affected by laryngeal cancer who underwent OPHL type II and III between 1995 to 2014 was carried out. Focusing on recurrence and its site (local, regional or distant), our cohort has been divided in two groups: patients showing recurrence (n = 108) vs those without recurrence (n = 711). Thirteen clinical-pathological parameters have been studied by univariate and multivariate analysis to identify possible correlations between recurrence and oncological outcomes (overall survival (OS), disease free survival (DFS), disease specific survival (DSS), laryngectomy free survival (LSF), laryngectomy free freedom (FFL). In multivariate analysis, we found 4 negative prognostic factors for recurrence: site of tumour (> supraglottic), cartilage invasion (> if present), perineural invasion (> if present) and type of OPHL (> in OPHL type III). The knowledge and detection of negative prognostic factors for the risk of recurrence (pN classification, cartilage involvement, perineural invasion, and thus the type of surgical treatment adopted) could increase the already well-established potentiality of OPHLs in treating cases with a safe indication after careful discussion in the tumour board.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available